Skip to content
Accessibility help

Search NICE…

Skip to content

Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About

Search results

Skip to results

Area of interest

Area of interestAntimicrobial prescribing (43)COVID-19 (36)

Type

TypeGuidance (3883)Indicators (267)News (230)NICE advice (496)Quality standards (255)Research recommendations (1922)

Status

StatusAwaiting development (327)Discontinued (382)In consultation (6)In development (423)Published (2460)Topic selection (289)

Last updated

Last updatedLast 3 months (60)Last 6 months (142)Last year (584)Last 3 years (1773)

Guidance programme

Guidance programmeAntimicrobial prescribing guidelines (25)Cancer service guidelines (10)Clinical guidelines (380)COVID-19 NHSE/I specialty guides (2)COVID-19 rapid guidelines (27)Diagnostics guidance (93)Health technology evaluations (38)Highly specialised technologies guidance (47)Interventional procedures guidance (950)Medical technologies guidance (154)Medicines practice guidelines (5)NICE guidelines (562)Public health guidelines (88)Safe staffing guidelines (7)Social care guidelines (47)Technology appraisal guidance (2035)

Advice programme

Advice programmeCOVID-19 rapid summaries (8)Evidence summaries (172)Medtech innovation briefings (324)

Showing 6676 to 6690 of 7680 results

Sort by

Anamorelin for treating anorexia and cachexia associated with non-small cell lung cancer [ID821]
Discontinued [GID-TA10105]
Result type
Technology appraisal guidance
Status
Discontinued
Melanoma (metastatic) - paclitaxel albumin-bound nanoparticles (1st line) [ID570]
Discontinued [GID-TAG440]
Result type
Technology appraisal guidance
Status
Discontinued
Durvalumab for untreated PD-L1 positive metastatic urothelial bladder cancer [ID1169]
Discontinued [GID-TA10324]
Result type
Technology appraisal guidance
Status
Discontinued
Sirukumab for previously treated moderate to severe active rheumatoid arthritis (ID1002)
Discontinued [GID-TA10180]
Result type
Technology appraisal guidance
Status
Discontinued
Venous leg ulcers - new treatments [ID394]
Discontinued [GID-TAG370]
Result type
Technology appraisal guidance
Status
Discontinued
Depatuxizumab mafodotin for treating recurrent EGFR-amplified glioblastoma [ID1244]
Discontinued [GID-TA10242]
Result type
Technology appraisal guidance
Status
Discontinued
Abemaciclib monotherapy for treating advanced hormone-receptor positive, HER2-negative breast cancer after endocrine therapy and chemotherapy [ID1347]
Discontinued [GID-TA10264]
Result type
Technology appraisal guidance
Status
Discontinued
Atezolizumab with paclitaxel for untreated advanced triple-negative breast cancer [ID2705]
Discontinued [GID-TA10570]
Result type
Technology appraisal guidance
Status
Discontinued
Ipilimumab for the adjuvant treatment of completely resected stage IV or high risk stage III melanoma [ID721]
Discontinued [GID-TAG479]
Result type
Technology appraisal guidance
Status
Discontinued
Idelalisib with bendamustine and rituximab for previously treated chronic lymphocytic leukaemia [ID839]
Discontinued [GID-TA10109]
Result type
Technology appraisal guidance
Status
Discontinued
Prostate cancer (hormone refractory) - atrasentan [ID390]
Discontinued [GID-TAG379]
Result type
Technology appraisal guidance
Status
Discontinued
Enzalutamide for the treatment of hormone refractory prostate cancer TA316
Discontinued [GID-TA10267]
Result type
Technology appraisal guidance
Status
Discontinued
Nivolumab with ipilimumab for adjuvant treatment of completely resected stage III or IV melanoma [ID1610]
Discontinued [GID-TA10499]
Result type
Technology appraisal guidance
Status
Discontinued
Everolimus with exemestane for treating HER2-negative hormone-receptor-positive breast cancer after endocrine therapy [ID965]
Discontinued [GID-TA10028]
Result type
Technology appraisal guidance
Status
Discontinued
Ofatumumab for the maintenance treatment of relapsed chronic lymphocytic leukaemia [ID732]
Discontinued [GID-TAG482]
Result type
Technology appraisal guidance
Status
Discontinued

Previous page
1
…
444
445
Current page 446
447
448
…
512
Page 446 of 512
Next page

Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Knowledge resources

About NICE
Into practice
Get involved with NICE
Jobs
News
Newsletters and alerts
Contact us
Leave feedback
Reusing our content
NICE UK Open Content Licence
Syndicate our content
Events

Facebook
X
YouTube
LinkedIn

Accessibility
Freedom of information
Glossary
Terms and conditions
Privacy notice
Cookies

© NICE 2024. All rights reserved. Subject to Notice of rights.